Total Payments
$1,297
2024 Payments
$384.71
Companies
12
Transactions
72
Medicare Patients
1,812
Medicare Billing
$144,916
Payment Breakdown by Category
Food & Beverage$1,285 (99.1%)
Education$11.90 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,285 | 71 | 99.1% |
| Education | $11.90 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $425.35 | 21 | $0 (2024) |
| ABBVIE INC. | $292.30 | 9 | $0 (2024) |
| Novo Nordisk Inc | $281.47 | 25 | $0 (2024) |
| Eisai Inc. | $89.54 | 5 | $0 (2018) |
| Merck Sharp & Dohme LLC | $33.60 | 2 | $0 (2024) |
| Boston Scientific Corporation | $32.50 | 2 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $30.33 | 2 | $0 (2017) |
| PFIZER INC. | $28.34 | 2 | $0 (2020) |
| AngioDynamics, Inc. | $24.80 | 1 | $0 (2023) |
| Abbott Laboratories | $22.91 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $384.71 | 13 | ABBVIE INC. ($162.25) |
| 2023 | $154.85 | 5 | AbbVie Inc. ($130.05) |
| 2020 | $204.86 | 11 | AstraZeneca Pharmaceuticals LP ($128.23) |
| 2018 | $236.30 | 23 | Novo Nordisk Inc ($139.66) |
| 2017 | $316.40 | 20 | AstraZeneca Pharmaceuticals LP ($86.47) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2020 | PFIZER INC. | LYRICA (Drug), FLECTOR, COLOGUARD | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $64.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 08/27/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Diabetes | ||||||
| 08/27/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: Diabetes | ||||||
| 08/20/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 08/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Diabetes | ||||||
| 07/30/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: Diabetes | ||||||
| 07/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 07/16/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 07/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 05/31/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: Diabetes | ||||||
| 05/14/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 05/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Diabetes | ||||||
| 04/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 04/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Diabetes | ||||||
| 03/29/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Diabetes | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 649 | 752 | $366,673 | $49,725 |
| 2022 | 10 | 533 | 632 | $289,495 | $41,198 |
| 2021 | 7 | 328 | 404 | $187,846 | $29,003 |
| 2020 | 5 | 302 | 462 | $81,163 | $24,991 |
Total Patients
1,812
Total Services
2,250
Medicare Billing
$144,916
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 231 | 231 | $132,531 | $15,567 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 254 | $143,174 | $14,749 | 10.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $27,240 | $6,746 | 24.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 44 | $12,320 | $3,158 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 49 | $19,634 | $2,591 | 13.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $10,302 | $2,387 | 23.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 50 | $5,213 | $1,699 | 32.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 20 | $7,970 | $1,047 | 13.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $2,884 | $951.16 | 33.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 15 | $3,738 | $546.59 | 14.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $1,667 | $282.92 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 239 | $134,456 | $14,306 | 10.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 141 | 141 | $81,097 | $10,909 | 13.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $16,944 | $4,454 | 26.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 48 | 49 | $11,956 | $3,287 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 50 | $20,013 | $2,658 | 13.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 27 | $10,746 | $2,049 | 19.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 54 | $5,562 | $1,820 | 32.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 15 | 23 | $5,751 | $868.61 | 15.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $2,266 | $742.23 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $704.00 | $104.76 | 14.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $45,243 | $10,757 | 23.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 135 | $84,006 | $9,666 | 11.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 91 | $36,335 | $3,868 | 10.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 38 | 38 | $9,272 | $2,480 | 26.7% |
About Dr. Donna Catanzaro, MD
Dr. Donna Catanzaro, MD is a Internal Medicine healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306838578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Catanzaro, MD has received a total of $1,297 in payments from pharmaceutical and medical device companies, with $384.71 received in 2024. These payments were reported across 72 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,285).
As a Medicare-enrolled provider, Catanzaro has provided services to 1,812 Medicare beneficiaries, totaling 2,250 services with total Medicare billing of $144,916. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Somerset, NJ
- Active Since 08/16/2005
- Last Updated 01/17/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306838578
Products in Payments
- FARXIGA (Drug) $331.88
- QULIPTA (Drug) $246.23
- Victoza (Drug) $138.35
- Ozempic (Drug) $95.90
- AIRSUPRA (Drug) $93.47
- Belviq (Drug) $89.54
- GENERAL - PAIN MANAGEMENT (Device) $32.50
- VRAYLAR (Drug) $28.29
- Tresiba (Drug) $26.86
- BIOFLO (Device) $24.80
- FREESTYLE LIBRE 3 (Device) $22.91
- LAGEVRIO (Drug) $20.74
- Xultophy 100/3.6 (Drug) $20.36
- ANORO (Drug) $19.32
- UBRELVY (Drug) $17.78
- ZORYVE (Drug) $16.66
- XARELTO (Drug) $15.25
- INVOKANA (Drug) $15.08
- LYRICA (Drug) $14.63
- COLOGUARD (Device) $13.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Somerset
Dr. Timothy Lonesky, D.o, D.O
Internal Medicine — Payments: $60,297
Internal Medicine $60,297
Homer Nelson, Md, MD
Internal Medicine — Payments: $38,225
Internal Medicine $38,225
Jae Hong, Md, MD
Internal Medicine — Payments: $18,094
Internal Medicine $18,094
Dr. Deepak Jain, Md, MD
Internal Medicine — Payments: $14,061
Internal Medicine $14,061
Mohammad Afzal, Md, MD
Internal Medicine — Payments: $12,500
Internal Medicine $12,500
Dr. Tariq Rizvi, Md, MD
Internal Medicine — Payments: $11,662
Internal Medicine $11,662